This announcement is a separate document:
HARTFORD GREAT HEALTH CORP | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
00:02
The AI startup Liquid has achieved a valuation of 2.3 billion USD in its latest round of financing.
00:00
Russia's GDP grew by 3.1% year-on-year in the third quarter, matching previous estimates.
00:00
The latest research results support Harvard's findings: Novo-Nordisk A/S's weight loss drug Ozempic is associated with rare visual loss.
NVO-1.66%